Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-99
Corpus(Cr.) 1430.00 Latest NAV 329.0621 As on 29-10-2026
Equity(%) 94.15 52 Week High 346.361
Debt(%) 5.85 52 Week Low 268.586
Others(%) 0.00 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 29.65%
Top 10 Holdings 46.42%
Top 25 Holdings 79.27%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 68.48
Healthcare 24.39
Cash 5.83
Chemicals 1.28
Others 0.02
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.15
PE Ratio 40.80
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 7.62
Divis Laboratories Ltd. 6.15
NET CURRENT ASSETS 5.83
Dr. Reddys Laboratories Ltd. 5.24
Ajanta Pharma Ltd. 4.81
Gland Pharma Limited 4.06
Alkem Laboratories Limited 3.70
Apollo Hospitals Enterprises Ltd. 3.03
Caplin Point Laboratories Ltd. 3.02
Global Health Limited 2.96
Lupin Ltd 2.89
Ipca Laboratories Ltd. 2.81
Max Healthcare Institute Limited 2.80
Cohance Lifesciences Limited 2.79
Marksans Pharma Ltd. 2.25
Rainbow Childrens Medicare Limited 2.21
Glenmark Pharmaceuticals ltd 2.12
EQ- JUPITER LIFE LINE HOSPITALS LTD 2.09
Aurobindo Pharma Ltd. 2.07
Fortis Healthcare Ltd 2.02
PROCTER & GAMBLE HEALTH LIMITED 1.95
Anthem Biosciences Limited 1.80
Aster DM Healthcare Limited 1.76
Dr. Lal Pathlabs Limited 1.67
Biocon Ltd. 1.62

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.37% -1.84% 12.49% 12.19%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.60% 22.32% 15.08% 13.27%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 16.19% -0.6627 14.7120% 47.1545 -0.0331
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) -12.4772% 0.7528 -0.1697 15.3925 -1.1300
 
Back to Selection